Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies

BACKGROUND: Dalbavancin is a lipoglycopepetide antibiotic with activity against gram positive pathogens recently approved for treatment of acute bacterial skin and skin structure infections. Pending the introduction of antimicrobial susceptibility tests, we examined the utility of vancomycin inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunne, Michael W, Sahm, Dan, Puttagunta, Sailaja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389583/
https://www.ncbi.nlm.nih.gov/pubmed/25885674
http://dx.doi.org/10.1186/s12941-015-0081-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389583/
https://www.ncbi.nlm.nih.gov/pubmed/25885674
http://dx.doi.org/10.1186/s12941-015-0081-5

Ejemplares similares